Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways

Area of Science:

• Neuroscience
• Molecular Biology
• Toxicology

Background:

• Tetanus toxin causes spastic paralysis by binding neurons and blocking transmitter release.
• Exploiting tetanus toxin's trafficking properties requires a stable, functional recombinant form.

Purpose of the Study:

• To develop a recombinant single-chain tetanus toxin variant for therapeutic applications.
• To investigate the neuroparalytic and trafficking properties of a protease-deficient mutant.

Main Methods:

• Expressing a recombinant single-chain tetanus toxin in E. coli.
• Activating the recombinant toxin with enterokinase to form a dichain.
• Creating a protease-deficient mutant by substituting Glu(234) with Ala.
• Assessing neuroinhibitory and neuroparalytic activities in vitro and in vivo.

Main Results:

• A soluble, purifiable recombinant single-chain tetanus toxin was successfully produced.
• The activated dichain mimicked native toxin's activities, including inducing spastic paralysis in mice.
• A protease-deficient mutant (Glu234Ala) showed potent neuroprotective effects against tetanus toxin in vivo, outperforming the heavy chain.
• The mutant demonstrated efficacy in blocking tetanus toxin's neuroparalytic action in vitro.

Conclusions:

• Nicking is not essential for tetanus toxin's protease activity.
• The heavy chain is not the sole determinant of efficient tetanus toxin trafficking.
• The innocuous Glu234Ala mutant is a promising, superior alternative to the heavy chain for drug delivery to central neurons.